Results 31 to 40 of about 3,018 (196)

Successful Treatment of Pityriasis Rubra Pilaris with Ixekizumab

open access: yesCase Reports in Dermatology, 2018
Pityriasis rubra pilaris is an inflammatory dermatologic disorder of unknown cause and often confounded with psoriasis. It is characterised by hyperkeratotic follicular papules, scaly erythematous plaques, palmoplantar keratoderma, and a progression to ...
Kathrin Hanfstingl   +4 more
doaj   +1 more source

Successful treatment with cyclosporine and guselkumab for pityriasis rubra pilaris

open access: yesClinical Case Reports, 2022
A man with pityriasis rubra pilaris (PRP) showed no improvement in skin symptoms despite treatment with several drugs. The patient was diagnosed as having type 1 PRP. Combination therapy with cyclosporine and guselkumab improved his skin condition. Here,
Mai Nishimura   +4 more
doaj   +1 more source

Dermoscopy in general dermatology: A practical overview [PDF]

open access: yes, 2016
Over the last few years, dermoscopy has been shown to be a useful tool in assisting the noninvasive diagnosis of various general dermatological disorders.
Errichetti, Enzo, Stinco, Giuseppe
core   +1 more source

Ustekinumab-Induced Fatal Acute Heart Failure in a Young Female: A Case Report

open access: yesMethodist DeBakey Cardiovascular Journal, 2022
Data regarding short- and long-term cardiovascular complications of biological agents is lacking. Herein, the authors reported a case of abrupt onset of acute heart failure induced by ustekinumab treatment for resistant pityriasis rubra pilaris in a ...
Mahmoud Abdelnabi   +4 more
doaj   +1 more source

CARD14 gain-of-function mutation alone is sufficient to drive IL-23/IL-17-mediated psoriasiform skin inflammation in vivo [PDF]

open access: yes, 2018
Rare autosomal dominant mutations in the gene encoding the keratinocyte signaling molecule, Caspase Recruitment Domain-Containing Protein 14 (CARD14), have been associated with an increased susceptibility to psoriasis but the physiological impact of ...
Cheng, Phil   +11 more
core   +1 more source

The IL-23/IL-17 Pathway in Inflammatory Skin Diseases: From Bench to Bedside

open access: yesFrontiers in Immunology, 2020
Interleukin-17 (IL-17) is an essential proinflammatory cytokine, which is mainly secreted by the CD4+ helper T cells (Th17 cells) and subsets of innate lymphoid cells.
Taoming Liu   +7 more
doaj   +1 more source

A Perspective on the Use of NB-UVB Phototherapy vs. PUVA Photochemotherapy [PDF]

open access: yes, 2018
Narrowband UVB (NB-UVB) phototherapy and psoralen-UVA (PUVA) photochemotherapy are widely used phototherapeutic modalities for a range of skin diseases.
Ahmad   +119 more
core   +3 more sources

Photosensitive pityriasis rubra pilaris [PDF]

open access: yesAdvances in Dermatology and Allergology, 2016
Pityriasis rubra pilaris (PRP) is a rare, chronic papulosquamous skin disorder. The skin lesions rarely have a predilection to sun-exposed areas although it is known that natural sunlight and phototherapy can exacerbate PRP [1–4]. We present a case of a patient suffering from pityriasis rubra pilaris with photoexposed distribution and photosensitivity ...
Męcińska-Jundziłł, Kaja   +4 more
openaire   +2 more sources

Oral Alitretinoin for the Treatment of Recalcitrant Pityriasis Rubra Pilaris

open access: yesCase Reports in Dermatology, 2011
Treatment of pityriasis rubra pilaris is still challenging. We here present a 74-year-old woman who had not experienced stable remission of her skin symptoms during prior treatments including topical and systemic corticosteroids, phototherapy, orally ...
Laurenz Schmitt   +2 more
doaj   +1 more source

An expert system for the differential diagnosis of erythemato-squamous diseases [PDF]

open access: yes, 2000
Cataloged from PDF version of article.This paper presents an expert system for differential diagnosis of erythemato-squamous diseases incorporating decisions made by three classification algorithms: nearest neighbor classifier, naive Bayesian classifier ...
Emeksiz, N., Guvenir, H. A.
core   +1 more source

Home - About - Disclaimer - Privacy